Status not kept up to date
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
NCT04211948 · Ruijin Hospital · Updated 9 April 2021
- What is being tested
- robotic surgery; open surgery
- For
- Pancreatic Ductal Adenocarcinoma; Minimally Invasive Surgery
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 300 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 March 2019, ends Dec 2024. Registered 26 Dec 2019.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to determine whether robotic surgery has limitations in terms of patient age, tumor size, location, and vascular relationship when compared to open surgery for pancreatic cancer. Whether robotic surgery has advantages over intraoperative bleeding, operative time, postoperative complications (bleeding, infection, pancreatic fistula) and postoperative hospital stays compared to open surgery.And the differences in lymph nodes harvest and postoperative survival between two groups.
Sites
- Shanghai Ruijin HospitalShanghai, Shanghai Municipality, China